(HealthDay)—On average, glycemic control improved during lockdown among people living with type 1 diabetes, according to a study published online Dec. 23 in Diabetes Care.
Louis Potier, M.D., from Bichat Hospital in Paris, and colleagues conducted an observational assessment from a self-reported questionnaire on behavioral changes and glycemic information from flash glucose monitoring (FGM) during lockdown in 1,378 individuals living with type 1 diabetes. Change in the mean glucose level two months before and one month after the lockdown was the main outcome.
The researchers observed improvement in mean glucose from 9.1 ± 1.7 mmol/L to 8.7 ± 1.7 mmol/L. Decreased alcohol consumption, an increase in the frequency of FGM scans and in the number of hypoglycemic events, and an easier diabetes control perception were factors associated with better glycemic control (odds ratios, 1.75, 1.48, 1.67, and 1.71, respectively).
“Our study suggests that while the lockdown was a source of anxiety for many people with type 1 diabetes, it was also an opportunity to make positive behavioral changes,” the authors write. “Their persistence after easing of lockdown should be studied.”
Several authors disclosed financial ties to the biopharmaceutical and medical device industries.
Poor glycemic control may up risk for stroke, death in T2DM
Abstract/Full Text (subscription or payment may be required)
Copyright © 2020 HealthDay. All rights reserved.
Glycemic control in type 1 diabetes improved during lockdown (2020, December 31)
retrieved 31 December 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022